Case Studies
These case studies are reflective of many typical situations when a determination and diagnosis of RLS is reached:
MIRAPEX has no predicted P450 interactions an important consideration in patients on multiple medications.
MIRAPEX has no predicted P450 interactions an important consideration in patients on multiple medications. Contraindications
Learn more about dosing and administration of MIRAPEX
Learn more about dosing and administration of MIRAPEXLearn more about dosing and administration of MIRAPEX
IMPORTANT SAFETY INFORMATION ABOUT MIRAPEX: MIRAPEX tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
MIRAPEX may cause patients to fall asleep without any warning, even while doing normal daily activities, such as driving. When taking MIRAPEX, hallucinations may occur and sometimes patients may feel dizzy, sweaty or nauseated upon standing up. The most common side effects in clinical trials for RLS were nausea, headache, and tiredness. Patients should talk with their doctor if they experience these problems.
Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease and RLS.
This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.
Please see full Prescribing Information, including patient information.
